无症状腹主动脉瘤EVAR术后五年生存预后评分(Si-AAA)的开发与内部验证
本研究为单中心回顾性队列,纳入443例无症状腹主动脉瘤行EVAR患者,构建基于年龄、COPD、不适合状态、白蛋白和瘤径的0-7分预后评分,用于预测5年总生存。评分区分度可接受(乐观校正C指数0.713),低、中、高危组5年生存分别为82.5%、53.4%、23.8%,需外部验证后常规使用。
要点
- 评分含年龄>70岁、COPD、不适合状态、白蛋白≤3.5 g/dL、瘤径≥7 cm五项预测因子。
- 评分0-7分,乐观校正C指数0.713,校准良好。
- 低、中、高危组5年总生存分别为82.5%、53.4%、23.8%。
核心结论
- 包含年龄、COPD、不适合状态、血清白蛋白和瘤径的简易预后评分对EVAR术后5年总生存具有可接受的区分度和良好的校准。
- 该工具可能有助于风险分层和长期临床决策,但需在独立队列外部验证后方可常规临床应用。
研究设计与样本
- 单中心回顾性队列研究,筛查445例无症状腹主动脉瘤行EVAR患者,最终纳入443例完整病例。
- 使用多因素Cox比例风险回归识别5年死亡的独立预测因子,基于回归系数构建简易评分。
- 采用Harrell一致性指数评估模型性能,1,000次bootstrap重抽样进行内部验证并获得乐观校正C指数,bootstrap校准图评估校准。
主要发现
- 随访期间共发生133例死亡(30.0%),估计5年总生存率为62.8%(95%CI 57.8%-68.0%)。
- 5年死亡的独立预测因子包括年龄>70岁(aHR 1.66,95%CI 1.06-2.62;P=0.029)、COPD(aHR 1.70,95%CI 1.08-2.69;P=0.023)、不适合状态(aHR 2.32,95%CI 1.58-3.39;P<0.001)、血清白蛋白≤3.5 g/dL(aHR 2.80,95%CI 1.97-3.98;P<0.001)、腹主动脉瘤直径≥7 cm(aHR 1.59,95%CI 1.07-2.38;P=0.023)。
- 最终评分范围0-7分,表观C指数0.721,bootstrap验证后乐观校正C指数0.713。
- 风险分层显示低、中、高危组区分清晰,5年总生存分别为82.5%、53.4%、23.8%(log-rank P<0.001)。
关键数值与推荐
- 评分预测因子及赋值基于多因素Cox回归系数:年龄>70岁、COPD、不适合状态、血清白蛋白≤3.5 g/dL、瘤径≥7 cm。
- 连续预测因子采用时间依赖ROC分析得出的临床可解释阈值进行分类。
- 评分总分0-7分,表观C指数0.721,乐观校正C指数0.713。
- 低、中、高危组5年总生存分别为82.5%、53.4%、23.8%(log-rank P<0.001)。
临床怎么用
- 该评分可用于EVAR术前对无症状腹主动脉瘤患者进行5年生存风险分层,辅助长期临床决策。
- 评分使用年龄、COPD、不适合状态、血清白蛋白和瘤径五项常规可获得变量,简便易行。
- 在常规临床实施前,需在独立外部队列中验证该评分的区分度和校准。
局限性
- 该评分在单中心队列中开发和内部验证,需在独立队列外部验证后方可常规临床应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although endovascular aneurysm repair is widely used for the treatment of asymptomatic abdominal aortic aneurysm, long-term survival is influenced by patient comorbidities and aneurysm-related characteristics. This study aimed to develop and internally validate a prognostic scoring system for predicting 5-year overall survival after endovascular aneurysm repair. METHODS: A retrospective cohort study was conducted in patients with asymptomatic abdominal aortic aneurysm undergoing endovascular aneurysm repair. Candidate predictors included demographic, clinical, aneurysm-related, and laboratory variables. Multivariable Cox proportional hazards regression was used to identify independent predictors of 5-year mortality. Continuous predictors were categorized using clinically interpretable thresholds derived from time-dependent receiver operating characteristic analysis, and a simplified point-based score was constructed from regression coefficients. Model performance was assessed using Harrell's concordance index, and internal validation was performed using 1,000 bootstrap resamples to obtain an optimism-corrected concordance index. Calibration was evaluated using bootstrap-based calibration plots. RESULTS: A total of 445 patients were screened, and 443 complete cases were included in the final analysis. During follow-up, 133 deaths (30.0%) occurred. The estimated 5-year overall survival rate was 62.8% (95% confidence interval [CI], 57.8%-68.0%). Independent predictors of 5-year mortality included age >70 years (adjusted hazard ratio [aHR] 1.66, 95% CI 1.06-2.62; P = 0.029), chronic obstructive pulmonary disease (aHR 1.70, 95% CI 1.08-2.69; P = 0.023), unfit status (aHR 2.32, 95% CI 1.58-3.39; P < 0.001), serum albumin ≤3.5 g/dL (aHR 2.80, 95% CI 1.97-3.98; P < 0.001), and abdominal aortic aneurysm diameter ≥7 cm (aHR 1.59, 95% CI 1.07-2.38; P = 0.023). The final score ranged from 0 to 7. The apparent concordance index was 0.721, with an optimism-corrected concordance index of 0.713 after bootstrap validation. Risk stratification showed clear separation among low-, intermediate-, and high-risk groups (5-year overall survival: 82.5%, 53.4%, and 23.8%, respectively; log-rank P < 0.001). CONCLUSION: A simple prognostic scoring system incorporating age, chronic obstructive pulmonary disease, unfit status, serum albumin, and aneurysm diameter demonstrated acceptable discrimination and good calibration for predicting 5-year overall survival after endovascular aneurysm repair. This tool may assist in risk stratification and long-term clinical decision-making. As this score was derived and internally validated in a single-center cohort, external validation in independent cohorts is required before routine clinical implementation.
引用
- Prapassaro T, Jitcharoen N, Chinsakchai K, et al. Development and Internal Validation of the Si-AAA Prognostic Score for Five-Year Overall Survival after Endovascular Aneurysm Repair in Patients with Asymptomatic Abdominal Aortic Aneurysm. Ann Vasc Surg. 2026. PMID: 42838481. doi:10.1016/j.avsg.2026.09.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。